pharma · Thyroid eye disease · Thyroid Eye Disease · VRDN
Viridian Pharma
Viridian Pharma Ltd
Viridian Pharma trial registry — 15 ClinicalTrials.gov studies with program phase, status, and indication context.
200 Market Street, ELMWOOD PARK, NJ 07407, US HQ
2017 Founded
2 Employees
Public company Type
VRDN · NYSE Ticker
Company details
- Status
- Public
- HQ
- 200 Market Street, ELMWOOD PARK, NJ 07407, US
- Founded
- 2017
- Employees
- 2
- Programs
- 13
- Drugs
- 11
- Patents
- 3
Viridian Pharma clinical trials
Registry index of 15 ClinicalTrials.gov studies linked to Viridian Pharma programs — each row shows trial ID, program name, phase, status, and indication.
Viridian Pharma trial registry — 15 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Viridian Pharma.
-
VRDN-001-302 — Phase 3
Clinical update -
VRDN-001-301 — Phase 3
Clinical update -
VRDN-003-303 — Phase 3
Clinical update -
VRDN-003-302 — Phase 3
Clinical update -
VRDN-003-301 — Phase 3
Clinical update -
VRDN-001-101 — Phase 3
Clinical update -
VRDN-001 (Insulin-like growth factor-1 receptor [IGF-1R] inhibitor) — Phase 3
Clinical update -
Veligrotug (VRDN-001) — Phase 3
Clinical update